Jarro-Dophilus EPS By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Jarro-Dophilus EPS
Supplement: Jarro-Dophilus EPS by Jarrow Formulas
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Probiotic Bacteria Blend
Ingredient Group | Blend (non-nutrient/non-botanical) |
---|---|
Category | blend |
-
Lactobacillus rhamnosus R0011
Ingredient Group Lactobacillus rhamnosus Category bacteria
Pediococcus acidilactici R1001
Ingredient Group Pediococcus acidilactici Category bacteria
Bifidobacterium longum BB536
Ingredient Group Bifidobacterium longum Category bacteria
Bifidobacterium breve R0070
Ingredient Group Bifidobacterium breve Category bacteria
Lactobacillus helveticus R0052
Ingredient Group Lactobacillus helveticus Category bacteria
Lactobacillus casei R0215
Ingredient Group Lactobacillus casei Category bacteria
Lactobacillus plantarum R1012
Ingredient Group Lactobacillus plantarum Category bacteria
Lactococcus lactis subsp. lactis R1058
Ingredient Group Lactococcus lactis Category bacteria
Drugs that interact with Jarro-Dophilus EPS by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
1 Capsule(s)
|
Servings per container | 60 |
UPC/BARCODE | 790011030201 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Probiotic Bacteria Blend |
0 NP
|
Blend (non-nutrient/non-botanical) |
--
|
Lactobacillus rhamnosus R0011 |
0 NP
|
Lactobacillus rhamnosus |
|
Pediococcus acidilactici R1001 |
0 NP
|
Pediococcus acidilactici |
|
Bifidobacterium longum BB536 |
0 NP
|
Bifidobacterium longum |
|
Bifidobacterium breve R0070 |
0 NP
|
Bifidobacterium breve |
|
Lactobacillus helveticus R0052 |
0 NP
|
Lactobacillus helveticus |
|
Lactobacillus casei R0215 |
0 NP
|
Lactobacillus casei |
|
Lactobacillus plantarum R1012 |
0 NP
|
Lactobacillus plantarum |
|
Lactococcus lactis subsp. lactis R1058 |
0 NP
|
Lactococcus lactis |
|
Other Ingredients: |
Potato Starch
Magnesium Stearate
Vitamin C
Vegetarian capsule
Forms
|
---|
Label Statments:
Suggested/Recommended/Usage/Directions |
- Usage: Take 1 capsule up to 4 times per day with water or juice, preferably on an empty stomach, or as directed by your qualified healthcare professional.
|
---|---|
Brand IP Statement(s) |
- Jarro-Dophilus EPS is a Stable-Dophilus probiotic due to its shelf life stability at room temperature and its enteric coating delivery system, which protects the beneficial probiotic strains while in transit through the stomach's acidic environment.
- Enhanced Probiotic System
- EnteroGuard
- EnteroGuard ensures the maximum survival of probiotic bacteria to the small intestines, and hence enhances their effectiveness.
- 2018 Jarrow Formulas
- Jarro-Dophilus EPS is ideal for traveling when refrigeration is not readily available.
- Strains Matter: Jarrow Formulas' Probiotics Contain Documented Strains
- Star Technology Lallemand
|
General Statements |
- The delivery system ensures that a maximum number of viable cells are delivered into the intestinal tract, where they can fully exert their beneficial effects.
- With Clinically Documented Strains
- 5 billion per capsule
8 strains
Intestinal & Immune Function & Health
- Capsules are individually blister packed to help ensure shelf stability.
|
Formula |
- The strains in Jarro-Dophilus EPS are selected from the following 4 genera:
Lactobacillus, Bifidobacterium, Lactococcus and Pediococcus.
Probiotic strains such as B. longum BB536, L. rhamnosus R0011 and L. helveticus R0052 are well characterized and have been shown to have the ability to interact, via multiple mechanisms of action, with the intestinal tract and the microbial ecosystem within it. These strains have been clinically shown to have a positive influence on the composition of the intestinal microflora, promote intestinal health and support immune response.
- Contains: Milk and soy (in trace amounts).
|
Storage |
- Storage Instructions: Jarro-Dophilus EPS is room temperature stable and does not require refrigeration. Refrigeration will, however, extend the shelf-life. Avoid temperatures above 77(0)F (25(0)C).
- Room Temperature Stable
No Refrigeration Required
- EnteroGuard
Ensures Maximum Survival + Room Temperature Stable
77(0)F (25(0)C)
|
Precautions |
- Keep out of the reach of children.
- Contains: Milk and soy (in trace amounts).
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
FDA Statement of Identity |
- Probiotic Supplement
|
General |
- 02418JEPS PROD # 103020
|
Formulation |
- No wheat, gluten, egg, fish/shellfish, or peanuts/tree nuts.
- Vegetarian V
|
Seals/Symbols |
- Gluten free
Vegetarian V
Veggie Caps V
|
Brand Information
See all products by this brand
Made in Canada by Lallemand Health Solutions, Inc. for | |
---|---|
Name | Jarrow Formulas Superior Nutrition and Formulation |
Street Address | P.O. Box 35994 |
City | Los Angeles |
State | CA |
ZipCode | 90035-4317 |
Web Address | www.Jarrow.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.